GNAQ_HUMAN - dbPTM
GNAQ_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID GNAQ_HUMAN
UniProt AC P50148
Protein Name Guanine nucleotide-binding protein G(q) subunit alpha
Gene Name GNAQ
Organism Homo sapiens (Human).
Sequence Length 359
Subcellular Localization Nucleus. Membrane. Nucleus membrane. Colocalizes with the adrenergic receptors, ADREN1A and ADREN1B, at the nuclear membrane of cardiac myocytes..
Protein Description Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems. Regulates B-cell selection and survival and is required to prevent B-cell-dependent autoimmunity. Regulates chemotaxis of BM-derived neutrophils and dendritic cells (in vitro) (By similarity)..
Protein Sequence MTLESIMACCLSEEAKEARRINDEIERQLRRDKRDARRELKLLLLGTGESGKSTFIKQMRIIHGSGYSDEDKRGFTKLVYQNIFTAMQAMIRAMDTLKIPYKYEHNKAHAQLVREVDVEKVSAFENPYVDAIKSLWNDPGIQECYDRRREYQLSDSTKYYLNDLDRVADPAYLPTQQDVLRVRVPTTGIIEYPFDLQSVIFRMVDVGGQRSERRKWIHCFENVTSIMFLVALSEYDQVLVESDNENRMEESKALFRTIITYPWFQNSSVILFLNKKDLLEEKIMYSHLVDYFPEYDGPQRDAQAAREFILKMFVDLNPDSDKIIYSHFTCATDTENIRFVFAAVKDTILQLNLKEYNLV
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
9S-palmitoylationTLESIMACCLSEEAK
CHHHHHHHHCCHHHH
1.0119801377
10S-palmitoylationLESIMACCLSEEAKE
HHHHHHHHCCHHHHH
3.2119801377
16UbiquitinationCCLSEEAKEARRIND
HHCCHHHHHHHHHCH
56.01-
50PhosphorylationLLLGTGESGKSTFIK
HHHHCCCCCCHHHHE
53.52-
52UbiquitinationLGTGESGKSTFIKQM
HHCCCCCCHHHHEEE
56.45-
53PhosphorylationGTGESGKSTFIKQMR
HCCCCCCHHHHEEEE
31.8817531806
65PhosphorylationQMRIIHGSGYSDEDK
EEEEECCCCCCHHHC
22.0128270605
67PhosphorylationRIIHGSGYSDEDKRG
EEECCCCCCHHHCCC
18.0428270605
68PhosphorylationIIHGSGYSDEDKRGF
EECCCCCCHHHCCCC
37.7428270605
72UbiquitinationSGYSDEDKRGFTKLV
CCCCHHHCCCCHHHH
52.99-
80PhosphorylationRGFTKLVYQNIFTAM
CCCHHHHHHHHHHHH
13.2818083107
85PhosphorylationLVYQNIFTAMQAMIR
HHHHHHHHHHHHHHH
19.8822210691
101PhosphorylationMDTLKIPYKYEHNKA
HHHCCCCCCCCCCHH
29.6726657352
102AcetylationDTLKIPYKYEHNKAH
HHCCCCCCCCCCHHH
38.5219608861
102UbiquitinationDTLKIPYKYEHNKAH
HHCCCCCCCCCCHHH
38.5219608861
103PhosphorylationTLKIPYKYEHNKAHA
HCCCCCCCCCCHHHH
19.3126657352
107UbiquitinationPYKYEHNKAHAQLVR
CCCCCCCHHHHHHHH
43.38-
120UbiquitinationVREVDVEKVSAFENP
HHCCCHHHHHCCCCH
41.14-
122PhosphorylationEVDVEKVSAFENPYV
CCCHHHHHCCCCHHH
38.0025599653
128PhosphorylationVSAFENPYVDAIKSL
HHCCCCHHHHHHHHH
23.6525599653
144S-palmitoylationNDPGIQECYDRRREY
CCCCHHHHHHHHHHE
2.1629575903
154PhosphorylationRRREYQLSDSTKYYL
HHHHEECCCCCCCCC
17.6217056873
158UbiquitinationYQLSDSTKYYLNDLD
EECCCCCCCCCCCHH
35.53-
183ADP-ribosylationQQDVLRVRVPTTGII
CCCEEEEECCCCCEE
23.43-
183ADP-ribosylationQQDVLRVRVPTTGII
CCCEEEEECCCCCEE
23.43-
187PhosphorylationLRVRVPTTGIIEYPF
EEEECCCCCEEECCC
21.95-
198PhosphorylationEYPFDLQSVIFRMVD
ECCCCHHHHEEEEEC
25.20-
209DeamidationRMVDVGGQRSERRKW
EEECCCCCCCHHHHH
39.5424141704
209Deamidated glutamineRMVDVGGQRSERRKW
EEECCCCCCCHHHHH
39.54-
209Formation of an isopeptide bondRMVDVGGQRSERRKW
EEECCCCCCCHHHHH
39.54-
252UbiquitinationENRMEESKALFRTII
CCCHHHHHHHHHHHH
53.0021906983
291PhosphorylationMYSHLVDYFPEYDGP
HHHHHHHHCCCCCCC
17.35-
345UbiquitinationRFVFAAVKDTILQLN
HHHHHHHHHHHHHHC
44.41-
354UbiquitinationTILQLNLKEYNLV--
HHHHHCCHHCCCC--
58.0121906983

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
53SPhosphorylationKinaseYPKA-PSP
53SPhosphorylationKinaseYPKA-GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
209QAmidation

24141704

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of GNAQ_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PK3CA_HUMANPIK3CAphysical
12704201
P85A_HUMANPIK3R1physical
12704201
GNAS3_HUMANGNASphysical
22939629
GNAS2_HUMANGNASphysical
22939629
ALEX_HUMANGNASphysical
22939629
GNAS1_HUMANGNASphysical
22939629
PPT1_HUMANPPT1physical
21988832
5NT3A_HUMANNT5C3Aphysical
21988832
LUM_HUMANLUMphysical
21988832
RIC8A_HUMANRIC8Aphysical
16629901
RIC8B_HUMANRIC8Bphysical
12652642

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
163000Capillary malformations, congenital (CMC)
185300Sturge-Weber syndrome (SWS)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of GNAQ_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-102, AND MASS SPECTROMETRY.

TOP